No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:126559400-126564400 |
Weak transcription |
Primary B cells from peripheral blood |
blood
|
2 |
chr5:126559400-126564400 |
Weak transcription |
GM12878-XiMat |
blood
|
3 |
chr5:126560400-126564400 |
Weak transcription |
Brain Substantia Nigra |
brain
|
4 |
chr5:126563000-126564600 |
Weak transcription |
Primary T killer naive cells fromperipheralblood |
blood
|
5 |
chr5:126563400-126564400 |
Enhancers |
NH-A |
brain
|
6 |
chr5:126563400-126564800 |
Enhancers |
HMEC |
breast
|
7 |
chr5:126563600-126564400 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
8 |
chr5:126563600-126564400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
9 |
chr5:126563800-126564600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
10 |
chr5:126564000-126564600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
11 |
chr5:126564000-126565000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
12 |
chr5:126564200-126564400 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
13 |
chr5:126564200-126564400 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
14 |
chr5:126564200-126564400 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
15 |
chr5:126564200-126564400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
16 |
chr5:126564200-126564400 |
Enhancers |
Adipose Nuclei |
Adipose
|
17 |
chr5:126564200-126564400 |
Enhancers |
Stomach Smooth Muscle |
stomach
|
18 |
chr5:126564200-126564400 |
Enhancers |
Spleen |
Spleen
|
19 |
chr5:126564200-126564400 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
20 |
chr5:126564200-126564600 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
21 |
chr5:126564200-126564600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|